CLL is regarded as similar to small lymphocytic lymphoma (SLL) by the World Health Organization (WHO) because they share several clinical features including immunophenotype (CD5+/CD19+ and CD5+/CD23+) and morphology; however, they differ with regard to the site of B-cell proliferation [3]. Here, CD5 is linked to B-cell chronic lymphocytic leukemia.